PDF) Filgrastim prophylaxis in elderly cancer patients in the real-life setting: a French multicenter observational study, the TULIP study
Common biological phenotypes characterize the acquisition of platinum-resistance in epithelial ovarian cancer cells
Physicians – Oral Sessions
ANNUAL REPORT 2016 OF EHA SWG « Elderly Task Force in Hematology Chair: Dr D. Bron
The Combination of Umbralisib Plus Ublituximab Is Active in Patients with Relapsed or Refractory Marginal Zone Lymphoma (MZL): Results from the Phase 2 Global Unity-NHL Trial - ScienceDirect
Country Onco Overview ARGENTINA - ppt video online download
Hematogenous Extramedullary Relapse in Multiple Myeloma – A Multicenter Retrospective Study in 127 Patients | Request PDF
Teva Secures European Approval of Trisenox® for First Line Treatment of Low to Intermediate Risk Acute Promyelocytic Leukemia (APL) - Chemdiv
EHOC 2019 - Sponsorhip Prospectus
Haematologica, Volume 107, Issue 7 by Haematologica - Issuu
annual report inglese 2011 def - Istituto di Ricerche Farmacologiche ...
Lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for autologous stem cell transplantation: an open label, single-arm, multicentre phase 2 trial - The Lancet Haematology
Teva Secures European Approval of Trisenox for First Line Treatment of Low to Intermediate Risk Acute Promyelocytic Leukemia » FINCHANNEL
ALL, AML MDS & Bone Marrow Failure - 2022 - British Journal of Haematology - Wiley Online Library
Antimicrobial prophylaxis in adults and children undergoing hematopoietic cell transplantation: 2021 Polish recommendations
Diana Mainella - Corporate Head of Uro-Oncology, Strategy and Commercial Excellence - Recordati | LinkedIn
Nonpegylated liposomal doxorubicin combination regimen in patients with diffuse large B‐cell lymphoma and cardiac comorbidity. Results of the HEART01 phase II trial conducted by the Fondazione Italiana Linfomi - Luminari - 2018 -
1 | Page EHA-SWG Aging and Hematology Annual Report 2017 MAIN SECTIONS (NOTE: sections 1-4 will be used for publication on EHA w
PUBLICATION - 2021 - Hematological Oncology - Wiley Online Library
Biomedicines | Free Full-Text | The Ups and Downs of STAT Inhibition in Acute Myeloid Leukemia
Teva Receives Positive Opinion from European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) to Exten
Nonpegylated liposomal doxorubicin combination regimen in patients with diffuse large B-cell lymphoma and cardiac comorbidity. R
ABSTRACT BOOK
